Jenna Carter
M.D., Ph.D.

Dissertation Mentor: Yubin Ge, Ph.D.

Research Focus: Investigating novel approaches to targeting therapy resistance in acute myeloid leukemia (AML) through targeting mitochondrial function and cellular metabolism.

Grants, Awards, Scholarships:

2019-2020 Rumble Fellowship
2018-2019 Board of Governors Medical Dean Merit Scholarship
2018-2019 Prentis Foundation Medical Scholarship
2017-2018 Board of Governors Medical Dean Merit Scholarship
2017-2018 Prentis Foundation Medical Scholarship
2011-2015 Dean's List, Michigan State University

Publications:

Wu S, Edwards H, Wang D, Liu S, Qiao X, Carter J, Wang Y, Taub JW, Wang G, and Ge Y. Inhibition of Mcl-1 Synergistically Enhances the Antileukemic Activity of Gilteritinib and MRX-2843 in Preclinical Models of FLT3-mutated Acute Myeloid Leukemia. Cells. 2022;11:2752.

Carter JL, Hege K, Kalpage HA, Edwards H, Hüttemann M, Taub JW, Ge Y. Targeting Mitochondrial Respiration for the Treatment of Acute Myeloid Leukemia. Biochem Pharmacol. 2020;182:114253.

Carter JL, Hege K, Yang J, Kalpage HA, Su Y, Edwards H, Hüttemann M, Taub JW, Ge Y. Targeting multiple signaling pathways: the new approach to acute myeloid leukemia therapy. Signal Transduction and Targeted Therapy. 2020;5:288.

Carter JL, Hege K, Kalpage HA, Edwards H, Hüttemann M, Taub JW, Ge Y. Targeting mitochondrial respiration for the treatment of acute myeloid leukemia. Biochem Pharmacol. 2020;182:114253.

Liu F, Kalpage HA, Wang D, Edwards H, Hüttemann M, Ma J, Su Y, Carter J, Li X, Polin L, Kushner J, Dzinic SH, White K, Wang G, Taub JW, Ge Y. Cotargeting of Mitochondrial Complex I and Bcl-2 Shows Antileukemic Activity against Acute Myeloid Leukemia Cells Reliant on Oxidative Phosphorylation. Cancers (Basel). 2020;12:2400.

Education: 
Michigan State University (Lyman Briggs Residential Science College), B.S.

Hometown:
White Lake, MI